Obesity blamed for rising incidence of kidney cancer in the UK

Cancer Research UK has reported that obesity and being overweight are to blame for the rise in kidney cancer in the UK, causing an extra 20,000 cases in the last 10 years, and that newly diagnosed cases of kidney cancer have risen by 40% over the past decade. Being overweight or obese are implicated in about 25% […] [...]

read more

Cabozantinib for advanced kidney cancer rejected for the second time by NICE

Unfortunately, the National Institute for Health and Care Excellence (NICE) have rejected cabozantinib (Cabometyx®) as a second-line treatment for metastatic kidney cancer for the second time. This is despite it’s proven effectiveness at prolonging the overall survival and progression-free survival of previously treated kidney cancer patients compared to everolimus in the METEOR trial. Further to […] [...]

read more

Advances in kidney cancer drug treatments shake up drug choices

The following article provides a comprehensive summary of the changing landscape in the choice of first and second-line drug treatments for advanced kidney cancer, with input from Dr Eric Jonasch, a professor of genitourinary medical oncology at The University of Texas MD Anderson Cancer Center and vice chair of the Kidney Cancer Guidelines Committee for […] [...]

read more

Treatment for hereditary leiomyomatosis renal cell carcinoma (HLRCC): a rare and aggressive form of kidney cancer

In this video, Dr W. Marston Linehan, chief of the Urologic Oncology Branch of the National Cancer Institute in America, discusses the treatment of hereditary leiomyomatosis and renal cell carcinoma (HLRCC). HLRCC is very rare inherited condition, in which patients are at risk of developing non-cancerous (benign) tumours in the muscle under the skin (cutaneous leiomyomas), […] [...]

read more

NHS cost savings plans could cause cancer patients to suffer

The Times published an article last week reporting on NHS cost savings plans outlined by Simon Stevens, Chief Executive of NHS England. The article references concerns raised by charities that the cuts will impact cancer patients in “chronic pain”. The plans are for the scrapping of prescriptions for low-value medicines, such as common painkillers, gluten-free foods and […] [...]

read more

Next steps on the NHS five-year forward view

The NHS Five Year Forward View was launched in October 2014 and sets out a series of practical and realistic steps for the NHS to deliver a better, more joined-up and more responsive NHS in England. Last week, NHS England launched the Next Steps on the NHS Five Year Forward View. The document states that […] [...]

read more
Showing 1 to 6 of 145 results